<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/630"/><api:result><api:object category="publication" id="630" last-affected-when="2024-03-17T09:06:42.37+00:00" last-modified-when="2024-03-17T09:06:42.37+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/630" created-when="2010-05-17T13:46:24.407+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-11-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="4208874" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="107827" last-modified-when="2022-12-29T02:07:31.727+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Methotrexate (MTX) is a folate antagonist widely used both as an anticancer drug and as an immunosupressant. Administration of an 8-day methotrexate and folinic acid regime may be associated with pleuritic chest pain and pneumonitis. We have reviewed the toxicity seen in 168 consecutive patients treated with low-dose MTX for persistent trophoblastic disease. Twenty-five per cent of patients developed serosal symptoms, pleurisy was the commonest complaint. The majority of patients had mild to moderate symptoms which were controlled with simple analgesia and did not necessitate a change in treatment; 11.9% had severe symptoms which necessitated a change in treatment. One patient developed a pericardial effusion and a second patient developed severe reversible peritoneal irritation. The possible aetiology and pathophysiology of methotrexate-induced serosal toxicity is discussed.</api:text></api:field><api:field name="acceptance-date" type="date" display-name="Date of acceptance"><api:date><api:day>30</api:day><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>methotrexate</api:keyword><api:keyword>pericarditis</api:keyword><api:keyword>peritonitis</api:keyword><api:keyword>pleurisy</api:keyword><api:keyword>pneumonitis</api:keyword><api:keyword>serosal complications</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>Â© 1999 Cancer Research Campaign.  From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.  To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="public-url" type="text" display-name="Public URL"><api:text>https://eprints.whiterose.ac.uk/id/eprint/107827</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Cancer Research UK</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>https://doi.org/10.1038/sj.bjc.6690804</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>11</api:month><api:year>2016</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>16</api:day><api:month>12</api:month><api:year>2016</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Public</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/1360449"><api:filename>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/107827/1/Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases%3A first reported case of methotrexate-induced peritonitis.pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>57481</api:file-size><api:mime-type>application/pdf</api:mime-type><api:checksum algorithm="md5">73B660B25D529F3B25164013F3BD83F2</api:checksum><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="1903262" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="DE203263-FF8F-4FD1-B432-94776933E005" last-modified-when="2016-12-16T11:17:11.657+00:00"><api:verification-status>verified</api:verification-status><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Methotrexate (MTX) is a folate antagonist widely used both as an anticancer drug and as an immunosupressant. Administration of an 8-day methotrexate and folinic acid regime may be associated with pleuritic chest pain and pneumonitis. We have reviewed the toxicity seen in 168 consecutive patients treated with low-dose MTX for persistent trophoblastic disease. Twenty-five per cent of patients developed serosal symptoms, pleurisy was the commonest complaint. The majority of patients had mild to moderate symptoms which were controlled with simple analgesia and did not necessitate a change in treatment; 11.9% had severe symptoms which necessitated a change in treatment. One patient developed a pericardial effusion and a second patient developed severe reversible peritoneal irritation. The possible aetiology and pathophysiology of methotrexate-induced serosal toxicity is discussed.</api:text></api:field><api:field name="acceptance-date" type="date" display-name="Date of acceptance"><api:date><api:day>30</api:day><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/10576662</api:text></api:field><api:field name="c-goldoa" type="boolean" display-name="Gold Open Access?"><api:boolean>false</api:boolean></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Adult</api:keyword><api:keyword>Antimetabolites, Antineoplastic</api:keyword><api:keyword>Female</api:keyword><api:keyword>Humans</api:keyword><api:keyword>Leucovorin</api:keyword><api:keyword>Methotrexate</api:keyword><api:keyword>Pericarditis</api:keyword><api:keyword>Peritonitis</api:keyword><api:keyword>Pleurisy</api:keyword><api:keyword>Pregnancy</api:keyword><api:keyword>Serositis</api:keyword><api:keyword>Trophoblastic Neoplasms</api:keyword><api:keyword>Uterine Neoplasms</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>16</api:day><api:month>12</api:month><api:year>2016</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Original research article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record><api:record format="native" id="1518147" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/sj.bjc.6690804" last-modified-when="2023-05-20T05:58:40.753+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjc.6690804</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record><api:record format="native" id="3522551" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032700599" last-modified-when="2023-02-21T17:11:37.857+00:00"><api:citation-count>21</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Methotrexate (MTX) is a folate antagonist widely used both as an anticancer drug and as an immunosupressant. Administration of an 8-day methotrexate and folinic acid regime may be associated with pleuritic chest pain and pneumonitis. We have reviewed the toxicity seen in 168 consecutive patients treated with low-dose MTX for persistent trophoblastic disease. Twenty-five per cent of patients developed serosal symptoms, pleurisy was the commonest complaint. The majority of patients had mild to moderate symptoms which were controlled with simple analgesia and did not necessitate a change in treatment; 11.9% had severe symptoms which necessitated a change in treatment. One patient developed a pericardial effusion and a second patient developed severe reversible peritoneal irritation. The possible aetiology and pathophysiology of methotrexate-induced serosal toxicity is discussed.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55491672400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6506722553</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403206142</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35109059400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6604053967</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10576662</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>17</api:day><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low dose methotrexate used in gestational trophoblastic diseases: First reported case of methotrexate induced peritonitis</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record><api:record format="native" id="630" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10576662" last-modified-when="2022-11-22T21:02:02.877+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Methotrexate (MTX) is a folate antagonist widely used both as an anticancer drug and as an immunosupressant. Administration of an 8-day methotrexate and folinic acid regime may be associated with pleuritic chest pain and pneumonitis. We have reviewed the toxicity seen in 168 consecutive patients treated with low-dose MTX for persistent trophoblastic disease. Twenty-five per cent of patients developed serosal symptoms, pleurisy was the commonest complaint. The majority of patients had mild to moderate symptoms which were controlled with simple analgesia and did not necessitate a change in treatment; 11.9% had severe symptoms which necessitated a change in treatment. One patient developed a pericardial effusion and a second patient developed severe reversible peritoneal irritation. The possible aetiology and pathophysiology of methotrexate-induced serosal toxicity is discussed.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">YCRC Department of Clinical Oncology, Weston Park Hospital NHS Trust, Sheffield, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10576662</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2362938</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Antimetabolites, Antineoplastic</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Leucovorin</api:keyword><api:keyword scheme="mesh">Methotrexate</api:keyword><api:keyword scheme="mesh">Pericarditis</api:keyword><api:keyword scheme="mesh">Peritonitis</api:keyword><api:keyword scheme="mesh">Pleurisy</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Serositis</api:keyword><api:keyword scheme="mesh">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh">Uterine Neoplasms</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>6690804</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>7</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Case Reports</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record><api:record format="native" id="881975" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10576662" last-modified-when="2023-11-21T18:56:43.86+00:00"><api:citation-count>9</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Methotrexate (MTX) is a folate antagonist widely used both as an anticancer drug and as an immunosupressant. Administration of an 8-day methotrexate and folinic acid regime may be associated with pleuritic chest pain and pneumonitis. We have reviewed the toxicity seen in 168 consecutive patients treated with low-dose MTX for persistent trophoblastic disease. Twenty-five per cent of patients developed serosal symptoms, pleurisy was the commonest complaint. The majority of patients had mild to moderate symptoms which were controlled with simple analgesia and did not necessitate a change in treatment; 11.9% had severe symptoms which necessitated a change in treatment. One patient developed a pericardial effusion and a second patient developed severe reversible peritoneal irritation. The possible aetiology and pathophysiology of methotrexate-induced serosal toxicity is discussed.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">YCRC Department of Clinical Oncology, Weston Park Hospital NHS Trust, Sheffield, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-8875-2164</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10576662</api:identifier><api:identifier scheme="pmc">PMC2362938</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh">Peritonitis</api:keyword><api:keyword scheme="mesh">Pleurisy</api:keyword><api:keyword scheme="mesh">Pericarditis</api:keyword><api:keyword scheme="mesh">Serositis</api:keyword><api:keyword scheme="mesh">Methotrexate</api:keyword><api:keyword scheme="mesh">Leucovorin</api:keyword><api:keyword scheme="mesh">Antimetabolites, Antineoplastic</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Female</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Open Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>27</api:day><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>research-article</api:item><api:item>Journal Article</api:item><api:item>Case Reports</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field><api:files><api:file proprietary-id="https://www.nature.com/articles/6690804.pdf"><api:file-url>https://www.nature.com/articles/6690804.pdf</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file><api:file proprietary-id="https://europepmc.org/articles/PMC2362938?pdf=render"><api:file-url>https://europepmc.org/articles/PMC2362938?pdf=render</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2924634" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1002898124" last-modified-when="2024-03-17T09:06:42.377+00:00"><api:citation-count>21</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01223051544.27</api:identifier></api:identifiers></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0654304405.17</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.014331105607.96</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01257257663.76</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Weston Park Cancer Centre</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01223762727.50</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10576662</api:identifier><api:identifier scheme="pmc">PMC2362938</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Pain Research</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Antimetabolites, Antineoplastic</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Leucovorin</api:keyword><api:keyword scheme="mesh">Methotrexate</api:keyword><api:keyword scheme="mesh">Pericarditis</api:keyword><api:keyword scheme="mesh">Peritonitis</api:keyword><api:keyword scheme="mesh">Pleurisy</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Serositis</api:keyword><api:keyword scheme="mesh">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh">Uterine Neoplasms</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.48</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record><api:record format="native" id="240823" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000083477700016" last-modified-when="2024-03-14T05:39:10.52+00:00"><api:citation-count>16</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">J-6898-2015</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000083477700016&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690804</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690804"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">252AC</api:identifier><api:identifier scheme="pubmed">10576662</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>methotrexate</api:keyword><api:keyword>pericarditis</api:keyword><api:keyword>peritonitis</api:keyword><api:keyword>pleurisy</api:keyword><api:keyword>pneumonitis</api:keyword><api:keyword>serosal complications</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record><api:record format="native" id="23592" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000083477700016" last-modified-when="2014-07-25T11:04:41.14+01:00"><api:citation-count>9</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Sharma</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Jagdev</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1991" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1991"/></api:links><api:last-name>Coleman</api:last-name><api:initials>RE</api:initials><api:first-names>RE</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>E</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="18786" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/18786"/></api:links><api:last-name>Hancock</api:last-name><api:initials>BW</api:initials><api:first-names>BW</api:first-names><api:separate-first-names><api:first-name>B</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lorigan</api:last-name><api:initials>PC</api:initials><api:first-names>PC</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>methotrexate</api:keyword><api:keyword>pericarditis</api:keyword><api:keyword>peritonitis</api:keyword><api:keyword>pleurisy</api:keyword><api:keyword>pneumonitis</api:keyword><api:keyword>serosal complications</api:keyword><api:keyword>PNEUMONITIS</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1037</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>11</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>81</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword origin="record-data" source="eprints">methotrexate</api:keyword><api:keyword origin="record-data" source="eprints">pericarditis</api:keyword><api:keyword origin="record-data" source="eprints">peritonitis</api:keyword><api:keyword origin="record-data" source="eprints">pleurisy</api:keyword><api:keyword origin="record-data" source="eprints">pneumonitis</api:keyword><api:keyword origin="record-data" source="eprints">serosal complications</api:keyword><api:keyword origin="record-data" source="manual">Adult</api:keyword><api:keyword origin="record-data" source="manual">Antimetabolites, Antineoplastic</api:keyword><api:keyword origin="record-data" source="manual">Female</api:keyword><api:keyword origin="record-data" source="manual">Humans</api:keyword><api:keyword origin="record-data" source="manual">Leucovorin</api:keyword><api:keyword origin="record-data" source="manual">Methotrexate</api:keyword><api:keyword origin="record-data" source="manual">Pericarditis</api:keyword><api:keyword origin="record-data" source="manual">Peritonitis</api:keyword><api:keyword origin="record-data" source="manual">Pleurisy</api:keyword><api:keyword origin="record-data" source="manual">Pregnancy</api:keyword><api:keyword origin="record-data" source="manual">Serositis</api:keyword><api:keyword origin="record-data" source="manual">Trophoblastic Neoplasms</api:keyword><api:keyword origin="record-data" source="manual">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antimetabolites, Antineoplastic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Leucovorin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Methotrexate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pericarditis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Peritonitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pleurisy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Serositis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Uterine Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Peritonitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pleurisy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pericarditis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Serositis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Methotrexate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Leucovorin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antimetabolites, Antineoplastic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Pain Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antimetabolites, Antineoplastic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Leucovorin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Methotrexate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pericarditis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Peritonitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pleurisy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Serositis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Trophoblastic Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Uterine Neoplasms</api:keyword><api:keyword origin="record-data" source="wos-lite">methotrexate</api:keyword><api:keyword origin="record-data" source="wos-lite">pericarditis</api:keyword><api:keyword origin="record-data" source="wos-lite">peritonitis</api:keyword><api:keyword origin="record-data" source="wos-lite">pleurisy</api:keyword><api:keyword origin="record-data" source="wos-lite">pneumonitis</api:keyword><api:keyword origin="record-data" source="wos-lite">serosal complications</api:keyword><api:keyword origin="record-data" source="wos">methotrexate</api:keyword><api:keyword origin="record-data" source="wos">pericarditis</api:keyword><api:keyword origin="record-data" source="wos">peritonitis</api:keyword><api:keyword origin="record-data" source="wos">pleurisy</api:keyword><api:keyword origin="record-data" source="wos">pneumonitis</api:keyword><api:keyword origin="record-data" source="wos">serosal complications</api:keyword><api:keyword origin="record-data" source="wos">PNEUMONITIS</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-0920" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662" title="British Journal of Cancer"><api:records><api:record source-name="summary"><api:title>British Journal of Cancer</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/630/relationships"/></api:object></api:result></api:response>